Close
Home - Press releases - Ethypharm and CTRS sign a partnership agreement to register and commercialise Orphacol® in China

Do you have
any question?

Contact us
10/11/2020

Ethypharm and CTRS sign a partnership agreement to register and commercialise Orphacol® in China

St-Cloud and Boulogne-Billancourt, France – November 10, 2020 – Ethypharm and Laboratoires CTRS announced today that they have entered into an exclusive agreement for the registration and commercialisation in the People’s Republic of China of the orphan medicine Orphacol® indicated for the treatment of patients with rare inborn errors in primary bile acid synthesis.

Press release

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.